Daily as of 3 Nov 16:00 ET
- Price
- between the two $117.59 vs 50 $120.12 / 200 $108.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 30 Jul 2025 · projected 13 bars out
INCY | Incyte GenomicsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$117.59
-$2.45 (-2.04%)
Incyte Genomics (INCY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Jul 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $120.39 vs 50 $107.06 / 200 $77.35
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 28 Jul 2025 · projected 2 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $118.28 vs 50 $115.15 / 200 $118.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 23 Oct 2026 bar 2 · projected 29 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Oct 2026 | 💀Death | 4-hour | 29 bars out | 2 bar cross test |
| 9 Jun 2026 | 🟨Golden | 4-hour | 11 bars out | Not tested |
| 12 Mar 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 30 Jul 2025 | 🟨Golden moderate | daily | 13 bars out | Not tested |
| week of 28 Jul 2025 | 🟨Golden flat | weekly | 2 bars out | Not tested |
About INCY
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$176M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge